Cancer Treatment Localization: Boston Oncology Arabia & SPIMACO Partner in Saudi Arabia In a groundbreaking move to enhance cancer care in the Middle East, Boston Oncology Arabia and SPIMACO have formalized their collaboration through a Memorandum of Understanding (MoU) aimed…
Phase 3 Studies for Azafaros Receive Key Regulatory Approvals, Set to Begin in 2025 Azafaros B.V. today revealed that its leading asset, nizubaglustat, has received Orphan Drug Designation (ODD) from both U.S. and European regulatory authorities for the treatment of…
QIAGEN Backs UK Initiative to Sequence 100,000 Newborn Genomes QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) has announced a strategic partnership with Genomics England to support the ambitious Generation Study, a groundbreaking initiative aiming to sequence the genomes of 100,000…
Partnering for Bispecific Antibodies and ADCs: Biocytogen and Acepodia Biocytogen (HKEX: 02315) and Acepodia (6976:TT) have announced a strategic partnership aimed at jointly evaluating a dual-payload bispecific antibody-drug conjugate (BsAD2C) program. This collaboration marks a significant step forward in their…
Wearable Data Integrated into EHR for Personalized Care by Validic At CES, Validic, a leader in digital health and personalized care technology, unveiled a new integration of physical activity data from wearables and smartwatches into electronic health record (EHR) systems.…
Viz.ai Partners with 3 Pharma Companies, Expands to 60,000 Providers Viz.ai, a leader in AI-powered disease detection and care coordination, has announced major achievements in its mission to revolutionize healthcare delivery. In 2024, the company formed partnerships with three of…
Patient Engagement Enhanced as Swoop Acquires MyHealthTeam Swoop, a leader in AI-driven healthcare marketing, has announced its acquisition of MyHealthTeam, the creator of one of the largest, most engaged opted-in patient social networks in the U.S. This acquisition is a…
Detection of Hyperkalemia Powered by AI Receives FDA Breakthrough Designation AccurKardia, a leading innovator in ECG-based diagnostic technology, has announced that its AI-powered AK+ Guard™ hyperkalemia detection software has received Breakthrough Device Designation from the U.S. Food and Drug Administration…
Diality Treats First Patient with Moda-flx Hemodialysis System Diality, a cutting-edge medical device company specializing in smart, flexible hemodialysis platforms, has announced the successful completion of the first-ever patient treatment with its Moda-flx Hemodialysis System™. This milestone was achieved in…
Stoke Therapeutics Announces Phase 3 Study Plans for Zorevunersen in Dravet Syndrome Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company focused on RNA medicine to restore protein expression, announced today that it has finalized its Phase 3 EMPEROR study design…